5-(Ethanesulfonyl)pyrimidine | 89882-07-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-(Ethanesulfonyl)pyrimidine
• 英文别名: 5-ethylsulfonylpyrimidine
• CAS: 89882-07-5
• 化学式: C₆H₈N₂O₂S
• 分子量: 172.21
• InChiKey: IYSRJICIWCZHTQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  68.3
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS QUINAZOLINE SUBSTITUÉS ET PROCÉDÉS D'UTILISATION
  申请人：ARAXES PHARMA LLC

  公开号：WO2017172979A1

  公开（公告）日：2017-10-05

  The present disclosure provides inhibitors of Ras protein. Also disclosed are methods to modulate the activity of Ras protein and methods of treatment of disorders mediated by Ras protein.

  本公开提供了Ras蛋白的抑制剂。还公开了调节Ras蛋白活性的方法以及治疗由Ras蛋白介导的疾病的方法。
• Filamin a binding anti-inflammatory and analgesic
  申请人：Pain Therapeutics, Inc.

  公开号：EP2918587A2

  公开（公告）日：2015-09-16

  A compound or its pharmaceutically acceptable salt, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula II, wherein the R group substituents, D, F, X, W and A are defined within.

  本发明公开了一种化合物或其药学上可接受的盐、组合物和方法，可提供镇痛和减轻炎症。一种考虑使用的化合物具有与式 II 相对应的结构，其中 R 基取代基、D、F、X、W 和 A 在式 II 中定义。
• Filamin A binding compounds and their use as anti-inflammatory and analgesic agents
  申请人：Pain Therapeutics, Inc.

  公开号：EP2918587B1

  公开（公告）日：2018-04-04
• FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC
  申请人：Burns Barbier Lindsay

  公开号：US20110105484A1

  公开（公告）日：2011-05-05

  A compound, its pharmaceutically acceptable salt, a composition containing the same and method of treatment that can provide analgesia and/or reduce inflammation are disclosed. A contemplated compound has a structure that corresponds to Formula A, wherein G, W, Q, Z, D, E, F, K, Y, d, e, f, k, n, m, and circle B and all R groups are defined within.
• FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC
  申请人：Burns Barbier Lindsay

  公开号：US20110105481A1

  公开（公告）日：2011-05-05

  A compound or its pharmaceutically acceptable salt, optionally including both individual enantiomeric forms, a racemate, diastereomers and mixtures thereof, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula A, wherein the R group substituents, d, e, f, k, n, m, D, E, F, K, G, P, Q, W, and Z are defined within.